Compare Bristol-Myers Squibb Co (BMY) vs First Solar, Inc. (FSLR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bristol-Myers Squibb Co vs First Solar, Inc. — how do they compare? Bristol-Myers Squibb Co trades at $64.7 (market cap $130.12B), while First Solar, Inc. trades at $223.87 (market cap $25.89B). The key difference: Bristol-Myers Squibb Co is far larger — about 5× First Solar, Inc.'s market cap, and Bristol-Myers Squibb Co pays a 3.96% dividend while First Solar, Inc. pays none. Which is the better fit depends on your goals.
| BMY | FSLR | |
|---|---|---|
Market Cap | $130.12B | $25.89B |
Sector | Health | Technology |
52-Week High | $65.89 | $318.30 |
52-Week Low | $42.60 | $180.05 |
Enterprise Value | $164.11B | $24.36B |
Dividend Yield | 3.96% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bristol-Myers Squibb Co
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
Read more on BMY →About First Solar, Inc.
First Solar designs and manufactures solar photovoltaic panels, modules, and systems for use in utility-scale development projects. The company's solar modules use cadmium telluride to convert sunlight into electricity. This is commonly called thin-film technology. First Solar is the world's largest thin-film solar module manufacturer. It has production lines in Vietnam, Malaysia, the United States, and a new factory under construction in India.
Read more on FSLR →
